Heparin protects basic and acidic FGF from inactivation
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The ability of heparin or that of hexuronyl hexosaminoglygan sulfate (HHS‐4) to protect basic or acidic fibroblast growth factor (FGF) from acid or heat inactivation has been analyzed. Both freshly prepared basic and acidic FGF stimulate the growth of baby hamster kidney (BHK‐21) cells exposed to medium supplemented with transferrin and insulin. Freshly prepared basic FGF was 10 fold more potent than acidic FGF. The addition of heparin to the medium decreased the potency of basic FGF while it potentiated that of acidic FGF. Upon storage of FGF at −80°C, a decline in potency of both basic and acidic FGF was observed. Heparin, when added to the medium, potentiated their activities, which became similar to that of freshly prepared basic FGF. In order to test whether heparin could protect basic or acidic FGF from inactivation, both mitogens were exposed to acid conditions (1% trifluoroacetic acid, pH 1.08, 2 h) or heat (65°C, 5 min) which inactivate basic or acidic FGF. When exposed to such treatment in the presence of heparin or HHS‐4, basic and acidic FGF retained their potency. The effect of heparin and HHS‐4 on the bioactivity of basic and acidic FGF is truly of a protective nature, since they had no effect when added after inactivation of the mitogens. Potentiation of the bioactivity of the protected mitogens or of the inactivated one could only be observed when cells were exposed to high heparin or HHS‐4 concentrations. This indicates that heparin and HHS‐4, in addition to protecting FGF from inactivation, also acts at another locus, as yet unidentified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of FGF-2 to heparan sulfate also imparts stability to the growth factor.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [40]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Epidermal Growth Factor and a New Derivative
Savage, C. R., & Cohen, S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44568-7 · Cited by 1,208
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation
Thornton, S. C., Mueller, S. N., & Levine, E. M. (1983) · Science · doi:10.1126/science.6635659 · Cited by 793
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Self-citationCultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth
Castellot, J., Addonizio, M., Rosenberg, R., & Karnovsky, M. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.2.372 · Cited by 679
Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., & Böhlent, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6963 · Cited by 613
Self-citationPurification of a fibroblast growth factor from bovine pituitary.
Gospodarowicz, D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41631-1 · Cited by 591
Self-citationPurification of the fibroblast growth factor activity from bovine brain.
Gospodarowicz, D., Bialecki, H., & Greenburg, G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34863-9 · Cited by 492
Self-citation
Research works printed but not linked: 1
- Gospodarowicz D., 1986, Methods in Enzymology
Cited by
Items 101–200 of 902
Heparin-Mimicking Polymers: Synthesis and Biological Applications
Paluck, S. J., Nguyen, T. H., & Maynard, H. D. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01147 · Cited by 189
Role of Growth Factors in Cutaneous Wound Healing: A Review
Kiritsy, C. P., & Lynch, S. E. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040050401 · Cited by 188
Injury‐induced release of basic fibroblast growth factor from bovine aortic endothelium
Gajdusek, C. M., & Carbon, S. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041390317 · Cited by 188
McCaffrey, T. A., Falcone, D. J., & Du, B. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041520226 · Cited by 185
Glypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165
Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G., & Ron, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10816 · Cited by 182
Damon, D. H., Lobb, R. R., D'Amore, P. A., & Wagner, J. A. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041380202 · Cited by 182
Mast cells in asthma – state of the art
Bradding, P., & Arthur, G. K. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12675 · Cited by 181
Shipley, G. D., Keeble, W. W., Hendrickson, J. E., Coffey, R. J., & Pittelkow, M. R. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041380310 · Cited by 180
Modes of FGF release in vivo and in vitro
D'Amore, P. A. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00046362 · Cited by 178
The extracellular regulation of growth factor action.
Flaumenhaft, R., & Rifkin, D. B. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.10.1057 · Cited by 177
“For example, heparin protects aFGF and bFGF from inactivation by heat or acid (Gospodarowicz and Cheng, 1986) and proteases (Rosengart et al., 1988; Saksela et al., 1988; Sommer and Rifkin, 1989).”
BackgroundHigh-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding.
Jellinek, D., Lynott, C. K., Rifkin, D. B., & Janjić, N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11227 · Cited by 149
Isolation, characterization, and localization of heparin-binding growth factors in the heart.
Casscells, W., Speir, E. H., Sasse, J., Klagsbrun, M., Allen, P. D., Lee, M., Calvo, B., Chiba, M., Häggroth, L., & Folkman, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114456 · Cited by 177
Biodegradable elastomeric scaffolds with basic fibroblast growth factor release
Guan, J., Stankus, J. J., & Wagner, W. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.002 · Cited by 175
Binding and release of basic fibroblast growth factor from heparinized collagen matrices
Wissink, M., Beernink, R. H. J., Pieper, J., Poot, A. A., Engbers, G. H. M., Beugeling, T., van Aken, W. G., & Feijén, J. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00418-x · Cited by 175
Wu, J., Zhu, J., He, C., Xiao, Z., Ye, J., Li, Y., Chen, A., Zhang, H., Li, X., Lin, L., et al. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b06047 · Cited by 174
Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease
Perry, G., Siedlak, S., Richey, P., Kawai, M., Cras, P., Kalaria, R., Galloway, P., Scardina, J., Cordell, B., & Greenberg, B. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03679.1991 · Cited by 172
“HSPG presumably plays this role because of its high negative charge, which allows it to concentrate and protect ligands from proteolysis while making insoluble complexes, as it apparently does for bFGF (Schreiber et al., 1985; Gospodarowicz and Cheng, 1986; Saksela et al., 1988).”
BackgroundDelli-Bovi, P., Curatola, A. M., Newman, K. M., Sato, Y., Moscatelli, D., Hewick, R. M., Rifkin, D. B., & Basilico, C. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.7.2933 · Cited by 172
“Although such an effect had already been demonstrated for the biological activities ofbFGF and acidic FGF (10), we believe that this is the first biochemical demonstration of such a dramatic effect.”
BackgroundFloege, J., Eng, E., Young, B. A., Couser, W. G., & Johnson, R. J. (1993) · Kidney International · doi:10.1038/ki.1993.55 · Cited by 171
Acidic and basic FGF in ocular media and lens: implications for lens polarity and growth patterns
Schulz, M. W., Chamberlain, C. G., Iongh, R. U. D., & McAvoy, J. W. (1993) · Development · doi:10.1242/dev.118.1.117 · Cited by 170
Sherman, L., Wainwright, D., Ponta, H., & Herrlich, P. (1998) · Genes & Development · doi:10.1101/gad.12.7.1058 · Cited by 169
“…HSPGs in the extracellular matrix can sequester and store secreted FGF proteins, and protect them from proteolytic degradation (Folkman et al. 1980; Gospodarowicz and Cheng 1986; Vlodavsky et al. 1987; Saksela et al. 1988; Cardon-Cardo et al. 1990; Gonzalez et al. 1990; Ishai-Michaeli et al. 1992).”
BackgroundDowd, C. J., Cooney, C. L., & Nugent, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5236 · Cited by 168
Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition
Allen, B. L., Filla, M. S., & Rapraeger, A. C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200106075 · Cited by 154
“One established function for FGFs is protection of the growth factors from endogenous proteases (Gospodarowicz and Cheng, 1986).”
BackgroundLillien, L. E., Sendtner, M., & Raff, M. C. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.635 · Cited by 153
“In the case of bFGF, which is active in a soluble state, association with the ECM has been reported to stabilize the protein (Gospodarowicz and Cheng, 1986; Saksela et al., 1988), and it has been suggested that ECM might serve as a storage site for FGF (Baird and Ling, 1987; Vlodavsky et al.”
BackgroundNakamura, T., Sugino, K., Titani, K., & Sugino, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55015-8 · Cited by 166
Electroimmunology and cardiac arrhythmia
Grune, J., Yamazoe, M., & Nahrendorf, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00520-9 · Cited by 166
Potentiation and Inhibition of bFGF Binding by Heparin: A Model for Regulation of Cellular Response
Fannon, M. W., Forsten, K. E., & Nugent, M. A. (2000) · Biochemistry · doi:10.1021/bi991895z · Cited by 170
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
Neufeld, G., Cohen, T., Gitay-Goren, H., Poltorak, Z., Tessler, S., Sharon, R., Gengrinovitch, S., & Levi, B.-Z. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437467 · Cited by 165
Polymers in Drug Delivery—State of the Art and Future Trends
Grund, S., Bauer, M., & Fischer, D. (2011) · Advanced Engineering Materials · doi:10.1002/adem.201080088 · Cited by 169
Regulation of functional muscarinic receptor expression in tracheal smooth muscle cells
Yang, C. M., Chou, S. P., Sung, T. C., & Chien, H. J. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.261.6.c1123 · Cited by 165
Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro
Rosengart, T. K., Johnson, W. V., Friesel, R. E., Clark, R., & Maciag, T. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80732-0 · Cited by 165
Lee, J., Yoo, J. J., Atala, A., & Lee, S. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.017 · Cited by 164
“Furthermore, binding of these growth factors to the heparinized collagen scaffolds was able to preserve their bioactivity, as this interaction with heparin appeared to protect the growth factors from denaturation and proteolytic degradation [19,25].”
The mast cell in health and disease
Rothe, M. J., Nowak, M., & Kerdel, F. A. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70264-i · Cited by 164
Matsuzaki, K., Yoshitake, Y., Matuo, Y., Sasaki, H., & Nishikawa, K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9911 · Cited by 164
Heparin and heparan sulfate bind interleukin-10 and modulate its activity
Salek‐Ardakani, S., Arrand, J. R., Shaw, D. M., & Mackett, M. (2000) · Blood · doi:10.1182/blood.v96.5.1879 · Cited by 165
The Fate of Intravenously Administered bFGF and the Effect of Heparin
Whalen, G. F., Shing, Y., & Folkman, J. (1989) · Growth Factors · doi:10.3109/08977198909029125 · Cited by 157
Raub, T. J., Kuentzel, S. L., & Sawada, G. A. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90442-b · Cited by 161
Neufeld, G., Gospodarowicz, D., Dodge, L., & Fujii, D. K. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041310119 · Cited by 161
Self-citationThe role of syndecans in disease and wound healing
Fears, C. Y., & Woods, A. (2006) · Matrix Biology · doi:10.1016/j.matbio.2006.07.003 · Cited by 164
Lindner, V, Olson, N. E., Clowes, A. W., & Reidy, M. A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116085 · Cited by 159
Chiodelli, P., Bugatti, A., Urbinati, C., & Rusnati, M. (2015) · Molecules · doi:10.3390/molecules20046342 · Cited by 159
“Heparin and free HSPGs bind FGF2 and protect it from heat and acidic inactivation [144] and from proteolytic degradation [145].”
BackgroundMaione, T. E., Gray, G. S., Hunt, A. J., & Sharpe, R. J. (1991) · PubMed · Cited by 159
Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo
Muir, J., Andrew, M., Hirsh, J., Weitz, J., Young, E., Deschamps, P., & Shaughnessy, S. (1996) · Blood · doi:10.1182/blood.v88.4.1314.bloodjournal8841314 · Cited by 153
Battler, A., Scheinowitz, M., Bor, A., Hasdai, D., Vered, Z., Segni, E. D., Varda‐Bloom, N., Nass, D., Engelberg, S., Eldar, M., et al. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90790-8 · Cited by 157
Nature of the interaction of growth factors with suramin
Middaugh, C. R., Mach, H., Burke, C. J., Volkin, D. B., Dabora, J. M., Tsai, P. K., Bruner, M. W., Ryan, J. A., & Marfia, K. E. (1992) · Biochemistry · doi:10.1021/bi00152a044 · Cited by 157
Koketsu, N., Berlove, D. J., Moskowitz, M. A., Kowall, N. W., Caday, C. G., & Finklestein, S. P. (1994) · Annals of Neurology · doi:10.1002/ana.410350413 · Cited by 157
Faber-Elman, A., Solomon, A., Abraham, J. A., Marikovsky, M., & Schwartz, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118385 · Cited by 142
McCarthy, T. L., & CANALIS, E. M. (1989) · Endocrinology · doi:10.1210/endo-125-4-2118 · Cited by 155
Presta, M., Maier, J. A. M., Rusnati, M., & Ragnotti, G. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400109 · Cited by 155
3 Fibroblast Growth Factor and Its Involvement in Developmental Processes
Gospodarowicz, D. (1990) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(08)60084-8 · Cited by 155
Self-citationImmunopathology and human mast cell cytokines
Bradding, P., & Holgate, S. T. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00010-4 · Cited by 153
Savagner, P., Vallés, A. M., Jouanneau, J., Yamada, K. M., & Thiery, J. P. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.8.851 · Cited by 133
“Heparin (Choay Laboratories, Paris, France) at 10 Mg/ml was added to the culture medium to stabilize the biological activity of aFGF (Gospodarowicz and Cheng, 1986).”
MethodMorrison, R. S., Keating, R. F., & Moskal, J. R. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490210111 · Cited by 152
Wu, D. Q., Kan, M. K., Sato, G. H., Okamoto, T., & Sato, J. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55368-0 · Cited by 136
Development of Approaches to Improve the Healing following Muscle Contusion
Kasemkijwattana, C., Ménétrey, J., Somogyi, G. T., Moreland, M. S., Fu, F. H., Buranapanitkit, B., Watkins, S. C., & Huard, J. (1998) · Cell Transplantation · doi:10.1016/s0963-6897(98)00037-2 · Cited by 150
Effects of acidic fibroblast growth factor on normal and ischemic myocardium.
Banai, S., Jaklitsch, M. T., Casscells, W., Shou, M., Shrivastav, S. M., Correa, R., Epstein, S. E., & Unger, E. F. (1991) · Circulation Research · doi:10.1161/01.res.69.1.76 · Cited by 149
ENDOTHELIAL CELLS IN CULTURE: A MODEL FOR STUDYING VASCULAR FUNCTIONS
Bachetti, T., & Morbidelli, L. (2000) · Pharmacological Research · doi:10.1006/phrs.1999.0655 · Cited by 148
Essential role of heparan sulfates in axon navigation and targeting in the developing visual system
Walz, A., McFarlane, S., Brickman, Y. G., Nurcombe, V., Bartlett, P. F., & Holt, C. E. (1997) · Development · doi:10.1242/dev.124.12.2421 · Cited by 135
Modulation of Mitogenic Activity of Fibroblast Growth Factors by Inorganic Polyphosphate
Shiba, T., Nishimura, D., Kawazoe, Y., Onodera, Y., Tsutsumi, K., Nakamura, R., & Ohshiro, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303468200 · Cited by 147
Type I collagen can function as a reservoir of basic fibroblast growth factor
Kanematsu, A., Marui, A., Yamamoto, S., Ozeki, M., Hirano, Y., Yamamoto, M., Ogawa, O., Komeda, M., & Tabata, Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.008 · Cited by 146
Nakamura, S., Nambu, M., Ishizuka, T., Hattori, H., Kanatani, Y., Takase, B., Kishimoto, S., Amano, Y., Aoki, H., Kiyosawa, T., et al. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31563 · Cited by 145
X-ray Crystal Structure of Human Acidic Fibroblast Growth Factor,
Blaber, M., DiSalvo, J., & Thomas, K. A. (1996) · Biochemistry · doi:10.1021/bi9521755 · Cited by 145
The complement system in schizophrenia: where are we now and what’s next?
Woo, J., Pouget, J. G., Zai, C. C. H., & Kennedy, J. L. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0479-0 · Cited by 143
Heparin-Chitosan Complexes Stimulate Wound Healing in Human Skin
Kratz, G., Arnander, C., Swedenborg, J., Back, M., Falk, C., Gouda, I., & Larm, O. (1997) · Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery · doi:10.3109/02844319709085478 · Cited by 143
Serum‐free culture of normal human melanocytes: Growth kinetics and growth factor requirements
Pittelkow, M. R., & Shipley, G. D. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400323 · Cited by 133
Inductive effects of fibroblast growth factor and lithium ion on Xenopus blastula ectoderm
Slack, J. M. W., Isaacs, H. V., & Darlington, B. G. (1988) · Development · doi:10.1242/dev.103.3.581 · Cited by 126
Gill, S., Wight, T. N., & Frevert, C. W. (2010) · The Anatomical Record · doi:10.1002/ar.21094 · Cited by 122
“The binding of a protein to glycosaminoglycans conceals proteolytic cleavage sites, which protects heparin binding growth factors, cytokines, and chemokines, from proteolytic degradation (Gospodarowicz and Cheng, 1986; Rosengart et al., 1989; Webb et al., 1993; Sadir et al., 2004; Ellyard et al., 2007).”
BackgroundFontaine, V., Kinkl, N., Sahel, J., Dreyfus, H., & Hicks, D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09662.1998 · Cited by 134
“The effect was dose-dependent and could be blocked by heat inactivation of FGF-2 (Gospodarowicz and Cheng, 1986) or with the polyanionic sulfated compound suramin, a heparin-like molecule known to inhibit FGF-2 actions in other model systems (Mascarelli et al., 1991).”
BackgroundBaird, A., & Böhlen, P. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-49295-2_7 · Cited by 136
The controversial role of mast cells in fibrosis
Bradding, P., & Pejler, G. (2018) · Immunological Reviews · doi:10.1111/imr.12626 · Cited by 129
Vascularization strategies for skin tissue engineering
Amirsadeghi, A., Jafari, A., Eggermont, L. J., Hashemi, S., Bencherif, S. A., & Khorram, M. (2020) · Biomaterials Science · doi:10.1039/d0bm00266f · Cited by 137
Yoon, J. J., Chung, H. J., Lee, H., & Park, T. G. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30843 · Cited by 135
“The above results additionally suggest that sustained release of bFGF from the scaffolds was very important to stimulate cell proliferation.(21,22) Considering the fact that the half-life of bFGF in serum conditions is very short, it is conceivable that bFGF slowly released from the scaffolds could maintain its thresh…”
ResultHuang, Y., & Liu, T.-J. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.12.009 · Cited by 134
On the existence of cytokines in invertebrates
Beschin, A., Bilej, M., Torreele, E., & BAETSELIER, P. D. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000901 · Cited by 132
Tardieu, M., Gamby, C., Avramoglou, T., Jozefonvicz, J., & Barritault, D. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500126 · Cited by 131
Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix.
Hageman, G. S., Kirchoff-Rempe, M. A., Lewis, G. P., Fisher, S. K., & Anderson, D. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6706 · Cited by 123
The structure of human acidic fibroblast growth factor and its interaction with heparin
Copeland, R. A., Ji, H. P., Halfpenny, A. J., Williams, R. W., Thompson, K. C., Herber, W. K., Thomas, K. A., Bruner, M. W., Ryan, J. A., Marquis-Omer, D., et al. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90441-k · Cited by 131
Extracellular matrix regulation of growth factor and protease activity
Flaumenhaft, R., & Rifkin, D. B. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90055-4 · Cited by 130
Andress, D. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28289 · Cited by 130
Carreira, C. M., LaVallee, T. M., Tarantini, F., Jackson, A., Lathrop, J. T., Hampton, B., Burgess, W. H., & Maciag, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22224 · Cited by 115
Heparinase inhibitsneovascularization.
Sasisekharan, R., Moses, M. A., Nugent, M. A., Cooney, C. L., & Langer, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1524 · Cited by 131
Sherman, L., Stocker, K. M., Morrison, R., & Ciment, G. (1993) · Development · doi:10.1242/dev.118.4.1313 · Cited by 117
Expression of basic fibroblast growth factor in the nervous system of early avian embryos
Kalcheim, C., & Neufeld, G. (1990) · Development · doi:10.1242/dev.109.1.203 · Cited by 129
Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds
Andreopoulos, F. M., & Persaud, I. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.11.019 · Cited by 128
Regulation of astrocyte proliferation by FGF-2 and heparan sulfate in vivo
Gomez-Pinilla, F., Vu, L., & Cotman, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02021.1995 · Cited by 120
Rusnati, M., & Presta, M. (1996) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02644769 · Cited by 131
Jouanneau, J., Gavrilović, J., Caruelle, D., Jaye, M., Moens, G., Caruelle, J. P., & Thiery, J. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2893 · Cited by 127
Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate
Sherwood, E. R., Fong, C., Lee, C., & Kozlowski, J. M. (1992) · Endocrinology · doi:10.1210/endo.130.5.1374018 · Cited by 127
Brain metastases in melanoma: Roles of neurotrophins
Denkins, Y., Reiland, J., Roy, M., Sinnappah-Kang, N. D., Galjour, J., Murry, B. P., Blust, J., Aucoin, R., & Marchetti, D. (2004) · Neuro-Oncology · doi:10.1215/s115285170300067x · Cited by 117
“Several studies have indicated that heparin and HS inhibit the mitogenic activity of angiogenic bFGF and at the same time stabilize and protect the molecule from inactivation (Gospodarowicz and Cheng, 1986).”
BackgroundCronauer, M. V., Schulz, W. A., Seifert, H., Ackermann, R., & Burchardt, M. (2003) · European Urology · doi:10.1016/s0302-2838(03)00005-8 · Cited by 124
Hamann, M. C. J., Tator, C. H., & Shoichet, M. S. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.01.030 · Cited by 124
“Heparin has been shown to stabilize FGF-2, protect it from enzymatic degradation, and potentiate its mitogenic effects (Edelman et al., 1991; Gallagher, 1994; Gospodarowicz and Cheng, 1986; Prestrelski et al., 1992; Safran et al., 2000; Sommer and Rifkin, 1989).”
BackgroundMethodInfluentialA Network Map of FGF-1/FGFR Signaling System
Raju, R., Palapetta, S. M., Sandhya, V. K., Sahu, A., Alipoor, A., Balakrishnan, L., Advani, J., George, B., Kini, K. R., Geetha, N. P., et al. (2014) · Journal of Signal Transduction · doi:10.1155/2014/962962 · Cited by 123
Binding of Interleukin-8 to Heparan Sulfate and Chondroitin Sulfate in Lung Tissue
Frevert, C. W., Kinsella, M. G., Vathanaprida, C., Goodman, R. B., Baskin, D. G., Proudfoot, A. E. I., Wells, T. N. C., Wight, T. N., & Martin, T. R. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2002-0084oc · Cited by 123
Dinbergs, I. D., Brown, L. R., & Edelman, E. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29822 · Cited by 125
Belloni, P., Carney, D. H., & Nicolson, G. L. (1992) · Microvascular Research · doi:10.1016/0026-2862(92)90004-9 · Cited by 122
In Vitro Models of Angiogenesis
Ucuzian, A. A., & Greisler, H. P. (2007) · World Journal of Surgery · doi:10.1007/s00268-006-0763-4 · Cited by 119
“This is suggested, for example, by studies showing the importance of FGF family members binding to ECM heparan sulfate proteoglycans.(42) As such, the role of fibrin interaction with growth factors in angiogenesis has been investigated.”
Riley, C. M., Fuegy, P. W., Firpo, M. A., Shu, X. Z., Prestwich, G. D., & Peattie, R. A. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.08.029 · Cited by 117
“Binding of growth factors with heparin has been shown to increase mitogenic activity, as well as enhance stability against both thermal and enzymatic denaturation [32].”
BackgroundFormulation Design of Acidic Fibroblast Growth Factor
Tsai, P. K., Volkin, D. B., Dabora, J. M., Thompson, K. C., Bruner, M. W., Gress, J., Matuszewska, B., Keogan, M., Bondi, J. V., & Middaugh, C. R. (1993) · Pharmaceutical Research · doi:10.1023/a:1018939228201 · Cited by 117
Heparan sulfate proteoglycans as transducers of FGF-2 signalling
Quarto, N., & Amalric, F. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.11.3201 · Cited by 98
Benezra, M., Vlodavsky, I., Ishai-Michaeli, R., Neufeld, G., & Bar‐Shavit, R. (1993) · Blood · doi:10.1182/blood.v81.12.3324.3324 · Cited by 116
Binding of heparin to basic fibroblast growth factor induces a conformational change
Prestrelski, S. J., Fox, G. M., & Arakawa, T. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90401-h · Cited by 116
Metadata
- Authors
- Gospodarowicz, D., & Cheng, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gospodarowicz, D.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1986-09
- Volume
- 128
- Issue
- 3
- Pages
- 475-484
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1972855766
- Cited by
- 853
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 18 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 22
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 20197)
- National Eye Institute (EY02186)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- heparin, basic fibroblast growth factor, acidic fibroblast growth factor, acid inactivation, thermal inactivation
- MeSH terms
- Animals, Cell Division, Cell Line, Fibroblast Growth Factors, Fibroblasts, Glycosaminoglycans, Cricetinae, Hot Temperature, Heparin, Hydrogen-Ion Concentration, Insulin, Kidney, Mesocricetus, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.